Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 2015 Aug 3;112(33):10491–10496. doi: 10.1073/pnas.1512424112

In situ proteolysis of the Vibrio cholerae matrix protein RbmA promotes biofilm recruitment

Daniel R Smith a, Manuel Maestre-Reyna b, Gloria Lee a, Harry Gerard a, Andrew H-J Wang b, Paula I Watnick a,1
PMCID: PMC4547210  PMID: 26240338

Significance

Adhesion to surfaces or biofilm formation is used by bacteria to build symbiotic relationships, cause disease, and survive outside of eukaryotic hosts. This process is often tightly controlled at the level of transcription. One type of biofilm formed by the diarrheal pathogen Vibrio cholerae depends on an ECM composed of exopolysaccharide and matrix-associated proteins, such as RbmA. RbmA has dual functions in reinforcement of the biofilm structure and recruitment of new cells. Here, we show that the recruitment function of RbmA is activated not at the transcriptional level but by a proteolytic event that depends on association of RbmA with the biofilm. This regulatory mechanism allows for the sequential implementation of the dual functions of RbmA.

Keywords: biofilm matrix, Vibrio cholerae, RbmA, proteolysis, VPS

Abstract

The estuarine gram-negative rod and human diarrheal pathogen Vibrio cholerae synthesizes a VPS exopolysaccharide-dependent biofilm matrix that allows it to form a 3D structure on surfaces. Proteins associated with the matrix include, RbmA, RbmC, and Bap1. RbmA, a protein whose crystallographic structure suggests two binding surfaces, associates with cells by means of a VPS-dependent mechanism and promotes biofilm cohesiveness and recruitment of cells to the biofilm. Here, we show that RbmA undergoes limited proteolysis within the biofilm. This proteolysis, which is carried out by the hemagglutinin/protease and accessory proteases, yields the 22-kDa C-terminal polypeptide RbmA*. RbmA* remains biofilm-associated. Unlike full-length RbmA, the association of RbmA* with cells is no longer VPS-dependent, likely due to an electropositive surface revealed by proteolysis. We provide evidence that this proteolysis event plays a role in recruitment of VPS cells to the biofilm surface. Based on our findings, we propose that association of RbmA with the matrix reinforces the biofilm structure and leads to limited proteolysis of RbmA to RbmA*. RbmA*, in turn, promotes recruitment of cells that have not yet initiated VPS synthesis to the biofilm surface. The assignment of two functions to RbmA, separated by a proteolytic event that depends on matrix association, dictates an iterative cycle in which reinforcement of recently added biofilm layers precedes the recruitment of new VPS cells to the biofilm.


The gram-negative bacterium Vibrio cholerae is both an inhabitant of estuarine and marine environments and a human diarrheal pathogen (1). In the aquatic environment and in the intestines of eukaryotic hosts, V. cholerae is most often found attached to surfaces (2). Surface attachment has been proven essential for intestinal colonization and is generally accepted to be important for survival in the environment (36). The genetic underpinning of surface attachment in natural aquatic environments has not been carefully investigated. However, there is evidence from the laboratory that pili and adhesins play a role in attachment to chitinous surfaces (5, 79), whereas synthesis of an exopolysaccharide-dependent biofilm matrix is required for colonization of the arthropod intestine (3).

Due to its unique small-molecule inducers, complex regulatory cascade, multicomponent matrix composition, and hypothesized environmental importance, the V. cholerae exopolysaccharide-dependent biofilm has been the subject of intense scrutiny. This biofilm requires matrix synthesis, a process that is regulated by environmental nutrients and secreted metabolites (1014). Many of these environmental signals alter the cytoplasmic level of cyclic-dimeric-GMP (c-di-GMP), most likely through the action of one of over 60 putative signal transduction proteins (15). The c-di-GMP, in turn, activates synthesis of the biofilm matrix.

The V. cholerae biofilm matrix includes the proteins RbmA, RbmC, and Bap1, as well as the VPS polysaccharide whose synthesis is encoded in two large operons, VpsI and VpsII, containing the genes vpsAvpsK and vpsLvpsQ, respectively (16, 17). Transcription of rbmA, rbmC, and bap1 is coregulated with the vps genes, and the encoded proteins are required for the 3D structure of the biofilm (16, 18). In particular, RbmA surrounds cells to augment biofilm accumulation and reinforce the biofilm structure, whereas Bap1 and RbmC adhere the biofilm to a surface (16, 19).

Two recent studies have elucidated the structure of RbmA (20, 21). This protein, which forms a dimer in solution, consists of two type III fibronectin (Fn III) domains joined by a flexible linker. RbmA dimers present two potential binding faces coined the “wide” and “narrow” grooves. The wide groove consists of two lobes of an RbmA monomer (Fig. 1A), whereas a surface formed by the union of two RbmA monomers comprises the narrow groove (Fig. 1B). In crystallographic studies, D-loop and O-loop conformations have been reported for the narrow groove of RbmA (20, 21). However, only the D-loop conformation is thought to be important for RbmA function (20).

Fig. 1.

Fig. 1.

RbmA is cleaved during biofilm formation. The structure of RbmA, showing the wide groove (A) and the D-loop and O-loop conformations of the narrow groove (B), is illustrated. RbmA monomers are blue and aqua, and the loop is yellow. (C) Images of WT V. cholerae MO10 (WT) or ΔrbmA mutant 24-h biofilms after vortexing with glass beads. (Scale bars: 0.5 cm.) (D) Quantification of biofilm-associated and planktonic cells in 24-h static cultures of WT V. cholerae (WT) and a ΔrbmA mutant (ΔA). *P < 0.05. (E) Western blot analyses of RbmA-FLAG in WT V. cholerae biofilms at various times. A 35-kDa band representing RbmA (R) and a 22-kDa band representing RbmA* (R*) are present. (F) Quantification of biofilm formation by WT V. cholerae over time.

Studies of V. cholerae biofilm development in real time using both conventional and superresolution microscopy have shown that RbmA accumulates only on the surface of cells that are competent to synthesize a VPS-dependent matrix (22). We noted that matrix-associated RbmA undergoes limited proteolysis to the C-terminal peptide RbmA* (16). We hypothesized that this proteolysis event might play a role in biofilm formation. Here, we show that association with VPS-producing cells promotes limited proteolysis of RbmA by the hemagglutinin protease (HAP) and accessory proteases, thus revealing an electropositive surface within the wide groove. We provide evidence that RbmA* gains the ability to bind VPS cells, thereby recruiting these cells to the biofilm surface. We propose a model in which proteolysis of RbmA increases recruitment of planktonic cells to the biofilm surface. These newly attached cells then continue the process of multilayer biofilm formation by initiating matrix synthesis.

Although a role for proteolysis of adhesins has previously been described in biofilm formation by gram-negative organisms (23, 24), the association of this phenomenon with biofilm accumulation rather than dispersal is unusual. We propose that the dependence of biofilm recruitment on RbmA proteolysis dictates an iterative cycle in which the existing biofilm matrix is reinforced by full-length RbmA before the addition of new layers of matrix-less planktonic cells. This sequence of events ensures the construction of a stable, multilayer biofilm.

Results

RbmA Promotes Both Biofilm Integrity and Recruitment of Planktonic Cells.

The biofilm matrix-associated protein RbmA maintains the integrity of the biofilm in the face of the mechanical stress that is likely to be encountered in aquatic environments (19). To demonstrate this function of RbmA, we imaged the aggregates produced by mechanically disrupting a biofilm formed over 24 h by WT V. cholerae strain MO10 or an isogenic ΔrbmA mutant. Although this treatment yielded large fragments of the WT V. cholerae biofilm, treatment of mutant biofilms lacking RbmA led to biofilm dispersal (Fig. 1C). A second function of RbmA is to augment biofilm accumulation. To demonstrate this function of RbmA, we cultured both WT V. cholerae and a ΔrbmA mutant for 24 h under static conditions and then quantified biofilm-associated and planktonic cells. Deletion of rbmA led to a reduction in biofilm-associated cells accompanied by an increase in cells remaining free in the medium (Fig. 1D). Therefore, RbmA has dual functions in preservation of biofilm integrity and recruitment of planktonic cells to the biofilm.

RbmA Proteolysis Does Not Induce Biofilm Dissolution.

In a previous study, we detected limited proteolysis of RbmA to RbmA*, a C-terminal, biofilm-associated peptide (16). To investigate the progression of proteolysis, we isolated biofilms at various times and detected affinity-tagged RbmA and RbmA* by Western blot analysis. Limited proteolysis of RbmA progressed over time without significant dissolution of the biofilm (Fig. 1 E and F).

HAP, PrtV, and VC0157 Participate in RbmA Proteolysis.

To study the impact of RbmA proteolysis on biofilm formation, our first goal was to inhibit this event by inactivating the responsible protease or proteases. We first added a variety of protease inhibitors to WT V. cholerae biofilms formed over 24 h and assessed cleavage of RbmA in biofilms after 48 h (Fig. S1A). The serine protease inhibitor PMSF, the general divalent cation chelator EDTA, and the Ca2+-specific chelator EGTA all diminished RbmA proteolysis. Supplementation with Ca2+, Mn2+, or Zn2+ in the presence of EDTA partially restored proteolysis. Based on these observations, we conclude that both metalloproteases and serine proteases are involved in cleavage of RbmA and that this cleavage is activated by specific divalent cations.

Fig. S1.

Fig. S1.

RbmA is cleaved by metalloproteases and serine proteases dependent on the ions Mn2+, Zn2+, and Ca2+, and it associates with cells that synthesize VPS. Western analysis of RbmA-FLAG in the 48-h biofilms formed by WT MO10 V. cholerae treated with the noted protease inhibitors or divalent cation supplements for 24 h (A); in 24-h and 48-h biofilms formed by C6706 carrying transposon insertions (Tn) or in frame deletions in known or putative secreted endoproteases of V. cholerae (B); in an MO10 Δhap mutant treated with the noted protease inhibitors for 24 h (C); in 24-h and 48-h biofilms formed by MO10 (M) or C6706 (C) carrying deletions of hap, prtV, VC0157, combinations of two, or all three (ΔT) (D); and associated with cells or cell-free supernatants (Sup) harvested from LB broth cultures incubated for 6 h at 27 °C with shaking (E). Duplicate cell pellets were washed with PBS. The ΔrbmA and ΔrbmAΔvpsL mutants expressing RbmA from a plasmid were tested. AEBSF, 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride. R indicates full-length RbmA, while R* indicates RbmA*. PI mix is protease inhibitor cocktail for bacterial cell lysate (P8465; Sigma).

Because RbmA is proteolyzed extracellularly, we targeted predicted or known extracellular endoproteases for mutagenesis and overexpression (Table S1). We first took advantage of an existing library of transposon insertion mutants in the C6706 strain background (25). We verified the transposon insertion sites for all protease mutants except the transposon insertion site reported to be within locus VC0157. Therefore, we constructed a strain carrying an in-frame deletion in VC0157 by allelic exchange. We then engineered a chromosomal C-terminal RbmA affinity tag into the parental strain and each protease-deficient strain, and detected RbmA in 24-h biofilms by Western blot analysis (16). Decreased cleavage of RbmA was noted in the biofilm formed by the hapA mutant (Fig. S1B).

Table S1.

Predicted or known extracellular endoproteases of V. cholerae

Locus Name Type
VC0157 Ser protease
VC0820 TagA Metalloprotease
VC1200 VesB Ser protease
VC1649 VesC Ser protease
VC1650 VchC Metalloprotease
VCA0148 TagA-related Metalloprotease
VCA0223 PrtV Ca2+-dependent metalloprotease
VCA0803 VesA Ser protease
VCA0865 Hap Ca2+-dependent zinc metalloprotease

We exploited the delayed cleavage of RbmA to determine the effect of ectopic expression of each secreted protease on RbmA cleavage at 24 h. Only overexpression of hapA resulted in early cleavage of RbmA (Fig. 2A). We then constructed strains carrying in-frame deletions in hapA, prtV, and VC0157 and found that much less RbmA proteolysis was present in the biofilms formed by the ΔhapA mutant after 48 h, but not in those biofilms formed by the other protease mutants (Fig. 2B). We conclude that the Ca2+-dependent Zn2+ metalloprotease HAP plays a dominant role in RbmA proteolysis. This finding is in agreement with the observation that the metal chelator EDTA prevents RbmA cleavage and the cations Zn2+ and Ca2+ restore it (26).

Fig. 2.

Fig. 2.

Proteases HAP, PrtV, and VC0157 cleave RbmA in a VPS-dependent manner near amino acid residue 75. Western blot analysis of RbmA-FLAG in 24-h and 48-h biofilms formed by WT V. cholerae overexpressing each of the known or putative secreted endoproteases (A); 48-h WT and protease mutant biofilms (B); ∆hapA mutant biofilms over time (C); 24-h and 48-h biofilms formed by a ∆hapA mutant expressing each of the known or putative secreted proteases of V. cholerae (D); 24-h, 48-h, or 72-h biofilms formed by V. cholerae with deletions of hap, prtV, VC0157, combinations of two, or all three (ΔT) (E); and biofilms formed by a VPS mutant overexpressing rbmA-FLAG cocultured with VPS or ΔrbmA mutant cells carrying a control vector or a vector allowing overexpression of HAP (F). EDTA (1 mM) was added where indicated. R, full-length RbmA; R*, RbmA*. (G) Sequence of RbmA indicating the secretion signal in green and the portion of RbmA that is cleaved in orange. The Cys residues predicted to participate in a disulfide bond are shown in blue.

The presence of a small amount of RbmA* in ΔhapA mutant biofilms at 48 h indicated that RbmA might be a substrate for additional proteases (Fig. 2B). To assess this possibility, we used Western blot analysis to follow RbmA cleavage over time in a ΔhapA mutant. As shown in Fig. 2C, RbmA* appeared at time points beyond 48 h. Therefore, we conclude that other proteases, in addition to HAP, are able to cleave RbmA.

To identify the accessory RbmA proteases, we first assessed RbmA* abundance in ΔhapA mutant biofilms in the presence and absence of the serine protease inhibitor 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride (Fig. S1C). This inhibitor completely abrogated cleavage of RbmA, suggesting the involvement of a serine protease. We then engineered ΔhapA mutant strains carrying the previously constructed plasmids for overexpression of each of the putative secreted proteases and assessed the presence of RbmA* in biofilms after 24 h and 48 h. After 24 h, overexpression of HAP alone yielded RbmA*, whereas at 48 h, overexpression of VC0157, PrtV, and VesA also increased levels of RbmA* (Fig. 2D). To determine which of these proteases was responsible for RbmA cleavage in the setting of native levels of expression, we assessed RbmA cleavage in protease mutant strains. As shown in Fig. 2E, although deletion of prtV partly decreased RbmA cleavage at 48 h and 72 h in a ΔhapA mutant background, only deletion of VC0157 was sufficient to abrogate RbmA* production. A similar result was observed in a C6706ΔhapA mutant (Fig. S1D). We conclude that PrtV and VC0157 are secondary RbmA proteases. Because supplementation with serine protease inhibitors and mutation of VC0157, but not prtV, completely arrested RbmA proteolysis in the ΔhapA mutant background, we hypothesize that the action of PrtV on RbmA proteolysis may be indirect, possibly through activation of VC0157. Furthermore, because these proteases yielded C-terminal cleavage products of similar size and no additional degradation products were observed, we speculate that this region of biofilm-associated RbmA is particularly susceptible to proteolysis.

Cell Association Protects RbmA* from Degradation by HAP.

In LB broth cultures, RbmA associates with surface-attached and planktonic V. cholerae in a VPS-dependent fashion, suggesting that VPS is synthesized not only by biofilm cells but also by planktonic cells (22, 27) (Fig. S1E). Because RbmA* was consistently more abundant in cell pellets than in cell-free supernatants, we hypothesized that VPS might modulate RbmA proteolysis. To test this possibility, we combined a VPS strain expressing RbmA with a ΔrbmA strain carrying a control vector or a vector encoding HAP and examined RbmA proteolysis after 48 h of static incubation. In this experiment, VPS is supplied by the ΔrbmA mutant, and RbmA is therefore predicted to be cell-associated. We noted limited proteolysis of RbmA to RbmA*, which was accelerated by overexpression of HAP (Fig. 2F). We then cocultured a VPS strain expressing RbmA from a plasmid with a VPS strain carrying an empty vector. In this case, full-length RbmA, but not RbmA*, was visible by Western blot analysis. We questioned whether this finding was the result of decreased HAP synthesis. To eliminate this possibility, we again cocultured two VPS strains; however, in this experiment, one strain carried a plasmid enabling overexpression of HAP. In this case, neither RbmA nor RbmA* was detected by Western blot analysis. To show that the disappearance of RbmA was the result of complete degradation by the metalloprotease HAP, we repeated this experiment with the addition of EDTA. Under these conditions, only full-length RbmA was observed. Our results demonstrate that HAP can access RbmA both in the presence and absence of VPS synthesis. However, when VPS is present, HAP cannot further proteolyze RbmA*. These findings suggest that association with cells that synthesize VPS protects RbmA* from degradation.

RbmA Is Cleaved Near Residue 75 to Yield RbmA*.

To identify the site of RbmA cleavage, we separated biofilm proteins on an SDS/PAGE gel, excised the band corresponding to RbmA*, and submitted this sample for liquid chromatography (LC)/MS. The most proximal RbmA-specific tryptic fragment identified in this analysis aligned with the sequence beginning at Lys residue 75 (Fig. 2G and Fig. S2A). These results indicate that, in addition to the 30-aa signal sequence, 44 amino acids are released by proteolysis to yield RbmA*, a 197-aa peptide with a predicted mass of 22 kDa. Three observations suggest that the cleavage site we identified by LC/MS is at or close to the actual cleavage site. First, the mass of RbmA* isolated from native biofilms, as estimated by Western blot analysis, was ∼22 kDa. Second, SDS/PAGE of a purified polypeptide corresponding to the sequence predicted for RbmA* yielded a 22-kDa band (Fig. S2B). Finally, RbmA is predicted to have a disulfide bond between residues C34 and C69. If cleavage removes this disulfide bond, SDS/PAGE performed under reducing conditions should alter the migration of RbmA but not RbmA*. This was, in fact, what we observed (Fig. S2C).

Fig. S2.

Fig. S2.

Identification and verification of RbmA cleavage site. (A) Peptides identified by LC/MS after excision of RbmA* from an SDS/PAGE gel. (B) Visualization of purified RbmA and RbmA* by Coumassie Blue staining of an SDS/PAGE gel. (C) Western blot analysis of RbmA-FLAG and the corresponding RbmA* cleavage product under nonreducing and reducing conditions.

Proteolysis of RbmA Augments Biofilm Accumulation.

We then used ectopic expression of HAP and RbmA* to explore the effect of RbmA proteolysis on surface association. Overexpression of HAP had no effect on biofilm integrity even after 2 d, when RbmA was completely proteolyzed to RbmA* (Figs. 2D and 3A). However, this proteolysis did result in a twofold increase in biofilm accumulation after 24 h, which was not observed in the absence of RbmA (Fig. 3B). This result suggested to us that RbmA* might play a role in biofilm accumulation. To determine if RbmA* could promote biofilm accumulation in the absence of full-length RbmA, we rescued a ΔrbmA mutant with RbmA* fused to the C-terminal type l secretion sequence (T1SS) of the V. cholerae RTX toxin to allow for secretion of RbmA* (28) (Fig. S3). As controls, we included plasmids expressing full-length RbmA, the T1SS alone, a Sec secretion-defective form of full-length RbmA fused to the T1SS, and RbmA* with no T1SS. Western blot analysis of biofilm cells expressing these constructs showed adequate expression with proteolytic removal of the T1SS motif following secretion (Fig. S4). RbmA* fused to the T1SS, but not RbmA* alone, rescued the biofilm accumulation defect of a ΔrbmA mutant (Fig. 3C). As a final test, we added similar amounts of purified RbmA or RbmA* to a ΔrbmA mutant. Again, we found that both full-length RbmA and RbmA*, but not heat-denatured RbmA*, rescued biofilm accumulation (Fig. 3D).

Fig. 3.

Fig. 3.

RbmA* augments biofilm association but does not disrupt biofilm integrity. (A) Images of 1- and 2-d-old biofilms formed by WT V. cholerae carrying either a control plasmid (pCTL) or a plasmid encoding HAP after vortexing with glass beads. (Scale bars: 0.5 cm.) Quantification of 24-h biofilms formed by WT V. cholerae or a ΔrbmA mutant carrying a control vector pBADlacZ (pCTL) or the same vector encoding HAP (B); carrying a vector encoding native RbmA (pA), the T1SS of V. cholerae RTX (pX), RbmA with a C-terminal T1SS instead of an N-terminal secretion signal sequence (psec-AX), RbmA* with a C-terminal T1SS (pA*X), or RbmA* with no means of secretion (pA*) (C); or supplemented with purified RbmA (A), RbmA* (A*), or boiled RbmA* (A*in) (D). Quantification of biofilm-associated (E) and planktonic (F) cells in 24-h cultures of WT V. cholerae, a ΔrbmA mutant, and ΔT mutant either alone or supplemented with purified RbmA*. (G) Quantification of 2-d-old biofilms formed by WT V. cholerae, a ΔrbmA mutant, and ΔT mutant either alone or supplemented with purified RbmA*. * indicates statistical significance.

Fig. S3.

Fig. S3.

N terminus (N-term) of RbmA is required for secretion. (A) Western blot analysis of RbmA peptides in cells (C) and supernatants (S) harvested from shaking cultures of ΔrbmA mutant cells carrying the indicated plasmids. Cells were collected by centrifugation at 10,000 × g for 10 min. (B) Diagram of RbmA truncations and fusions constructed for rescue experiments.

Fig. S4.

Fig. S4.

RbmA and RbmA* fused to the type 1 secretion motif of RTX results in removal of the secretion motif and minimal degradation at high expression levels. Western blot analysis of biofilms formed by ΔrbmA mutant cells carrying plasmids encoding RbmA-FLAG (pRbmA), RbmA-FLAG lacking the Sec secretion signal but C-terminally fused to the type 1 secretion motif of RtxA (psec-RbmA-RTX), and RbmA*-FLAG fused to the C-terminal type l secretion motif of RtxA (pRbmA*-RTX). Bands corresponding to the full-length fusion proteins, as well as peptides with the type 1 secretion motif cleaved, are shown.

To explore the role of native levels of RbmA proteolysis, we measured biofilm accumulation after 24 h and 48 h by WT V. cholerae, a ΔrbmA mutant, and a ΔhapΔVC1057ΔprtV triple-protease (ΔT) mutant either alone or supplemented with RbmA*. Because RbmA proteolysis had not yet begun, the biofilms formed by WT V. cholerae and the ΔT mutant after 24 h were not significantly different. Addition of purified RbmA* to the ΔT mutant culture resulted in a twofold increase in recruitment of planktonic cells to the biofilm (Fig. 3 E and F), similar to the effect produced by HAP overexpression (Fig. 3B). After 48 h, both ΔrbmA and ΔT biofilms showed significantly decreased accumulation compared with WT V. cholerae (Fig. 3G). However, unlike the ΔrbmA mutant biofilm, upon vortexing, the ΔT biofilm maintained its integrity (Fig. S5). Furthermore, the addition of purified RbmA* rescued the accumulation defect of the ΔT mutant. Taken together, these results support an independent role for RbmA* in augmenting biofilm accumulation by WT V. cholerae and suggest that cleavage of RbmA does not affect biofilm integrity.

Fig. S5.

Fig. S5.

Triple-protease mutant biofilm resists dispersion. Images of biofilms were formed over 48 h and then vortexed in the presence of glass beads. WT V. cholerae (WT); a ΔrbmA mutant; a mutant with the genes encoding the HAP, PrtV, and VC0157 proteases deleted (ΔT); or a mutant with the genes encoding all three proteases and rbmA deleted (ΔrbmAΔT) are shown.

Cleavage of RbmA Enables Binding to VPS Cells.

N-terminal proteolysis of RbmA removes the binding surface of one Fn III lobe, shifting the electrostatic potential of the wide groove from negative to positive (Fig. 4A). We therefore hypothesized that RbmA cleavage might alter its binding affinity. To test this possibility, we incubated purified full-length RbmA and RbmA* with a VPS+ or VPS ΔrbmA mutant for 1 h and assessed cell association. As shown in Fig. 4B, full-length RbmA bound only to VPS+ cells, but not to VPS cells. In contrast, RbmA* bound to the surface of both VPS+ and VPS cells. We propose that proteolysis of RbmA alters the surface potential of the wide groove, such that it binds to WT cells that have not initiated VPS synthesis. However, we cannot rule out the possibility that the cell envelope of a VPS mutant is altered such that it is not equivalent to the cell envelope of a WT cell.

Fig. 4.

Fig. 4.

Proteolysis of RbmA to RbmA* promotes biofilm recruitment but not invasion. (A) Wide grooves of RbmA and RbmA*. Electronegative surfaces are red, whereas electropositive surfaces are blue. The circle indicates the electropositive patch exposed in RbmA*. (B) Western blot analysis of affinity-tagged and purified RbmA or RbmA* attached to ΔrbmA (ΔA) or ΔrbmAΔvpsL (ΔAL) mutant cells. (CE) Projections onto the XZ or YZ plane of preformed WT tomato-labeled V. cholerae biofilms ectopically expressing HAP as indicated after incubation with GFP-labeled VPS mutant cells alone or with purified RbmA*. (Scale bars: 10 μm.) (F) Quantification of VPS cells per field for conditions shown in CE.

RbmA Proteolysis Increases Recruitment of VPS Cells to the Biofilm Surface.

We reasoned that biofilm-associated RbmA* might play an important role in recruitment of VPS cells to the biofilm surface. To test this possibility, we labeled WT and VPS cells with tomato and GFP, respectively, in similar chromosomal locations. We then incubated preformed biofilms containing either WT V. cholerae alone or expressing HAP with VPS cells and imaged these biofilms by confocal microscopy. On average, ∼10-fold more VPS cells were distributed along the surface of WT biofilms expressing HAP, but no VPS cells were observed within the biofilm (Fig. 4 C, D, and F). Because VPS cells invaded a preformed ΔrbmA mutant biofilm consistent with previous reports (27), such biofilms were not useful in studying the dependence of the recruitment phenotype on RbmA (Fig. S6). Instead, we incubated preformed WT biofilms with VPS cells supplemented with purified RbmA*. Again, on average, in the presence of RbmA*, ∼16-fold more VPS cells were recruited to the biofilm surface (Fig. 4 E and F).

Fig. S6.

Fig. S6.

VPS cells invade a ΔrbmA mutant biofilm. A z-axis projection of a preformed ΔrbmA mutant biofilm incubated with GFP-labeled ΔvpsL cells (VPS). Cells in the ΔrbmA mutant biofilm were stained with DAPI. (Scale bar: 10 μm.)

To determine whether increased recruitment of VPS cells to the biofilm surface correlated with increased incorporation into the biofilm, we formed biofilms by coincubating WT V. cholerae and VPS cells alone and with ectopically expressed HAP or purified RbmA*. After 24 h, entire pellicles were harvested and imaged, and the number of VPS cells incorporated per volume of biofilm-associated WT cells was quantified. We found that both ectopic expression of HAP and addition of purified RbmA* increased biofilm incorporation of VPS cells (Fig. S7). Taken together, these data support a model in which generation of RbmA* by the action of HAP increases recruitment of VPS cells to the surface of the forming biofilm but does not facilitate biofilm invasion.

Fig. S7.

Fig. S7.

RbmA proteolysis increases incorporation of VPS cells into forming biofilms. Projections onto the X–Y plane (above) and X–Z or Y–Z plane (below) of 3D reconstructions of biofilms formed by coculture of a GFP-labeled ΔvpsL mutant and tomato-labeled WT V. cholerae (WT) alone (A), supplemented with purified RbmA* (B), and carrying a vector encoding HAP (C). Mutant and WT were combined at a ratio of 1:100. (Scale bars: 10 μm.) (D) Quantification of the number of ΔvpsL cells per volume of WT cells. Two random fields of view were quantified in each of three independently formed pellicles.

Discussion

RbmA is a biofilm matrix-associated structural protein that functions both in biofilm accumulation and in reinforcement of the biofilm matrix. We were intrigued by the observation that RbmA undergoes limited proteolysis to the C-terminal peptide RbmA* without biofilm dissolution or loss of biofilm integrity. Here, we provide evidence that association of RbmA with VPS-producing cells promotes limited proteolysis of RbmA to RbmA*, which is carried out by HAP, PrtV, and VC0157. Unlike full-length RbmA, which binds only to cells that synthesize a VPS-dependent matrix, RbmA* can also bind to VPS cells. As a result, RbmA* increases recruitment of VPS cells to the surface of the forming biofilm.

In the laboratory, V. cholerae biofilms are formed in rich media that activate biofilm matrix synthesis in both surface-associated and, to a lesser extent, planktonic cells. However, in many natural environments, matrix synthesis is activated only after association with digestible surfaces, such as chitin, which provide the requisite nutritive signals. In such environments, recruitment of cells that have not initiated matrix synthesis to the biofilm surface may be particularly important for biofilm growth. We propose a model in which association of RbmA with the biofilm matrix after secretion from cells reinforces the matrix. RbmA then undergoes limited proteolysis of RbmA to RbmA*, thus promoting the recruitment of a new layer of planktonic cells. These cells, in turn, initiate matrix synthesis and continue the cycle (Fig. 5).

Fig. 5.

Fig. 5.

RbmA proteolysis in V. cholerae biofilm formation. (I) Cells secrete VPS and matrix proteins to form a new layer of the biofilm. (II) This new layer is reinforced by binding of RbmA to cells in a VPS-dependent manner. RbmA undergoes limited proteolysis to RbmA*. (III) RbmA* recruits new VPS cells to the surface of the biofilm. (IV) New cells secrete VPS and matrix proteins, and the cycle begins anew.

In bacterial biofilm formation, many roles for extracytoplasmic proteases have been described. In most cases, these proteases stimulate biofilm dispersion. For example, the V. cholerae chitin-binding protein GbpA is cleaved by HAP and PrtV, resulting in decreased attachment to chitin-coated beads (5, 24). Pseudomonas fluorescens biofilm formation is mediated by the outer membrane protein LapA (29, 30). When activated by the c-di-GMP–binding protein LapD, the periplasmic protease LapG cleaves LapA. Release of LapA from the cell surface results in biofilm dispersion (23, 3133). In contrast, proteolysis of RbmA augments biofilm accumulation.

In Staphylococcus epidermidis and Staphylococcus aureus, a proteolysis event that augments biofilm formation has been described in detail. The targets of proteolysis are the large homologous proteins SasG of S. aureus and AaP of S. epidermidis (34). These proteins consist of an N-terminal A domain, a series of B domains, and a C-terminal LPXTG motif, which anchors these proteins to the cell wall. The A domain mediates surface adhesion (34, 35). After cleavage from the A domain by a variety of bacterial and host proteins, the B domain promotes intercellular interactions by means of the formation of homodimers (3638). Although there are similarities between the roles of proteolysis in V. cholerae and staphylococcal biofilm formation, there are also important differences. Although RbmA function requires the VPS polysaccharide, Aap and SasG mediate biofilm formation in the absence of the staphylococcal biofilm polysaccharide (38). Furthermore, unique domains of Aap and SasG perform their respective functions, whereas RbmA consists of two similar domains, one of which is modified to carry out its second function. Finally, the A domains of Aap and SasG mediate surface attachment, a function that is carried out by the homologous proteins RbmC and Bap1 in V. cholerae.

When two functions are confined to one protein as they are in Aap, SasG, and RbmA, regulation of one by a conditional cleavage event allows these functions to be carried out sequentially. For instance, in the case of Aap and SasG, proteolysis enforces an order of operations in which surface attachment occurs before the formation of intercellular interactions. Partial proteolysis of RbmA occurs after association with VPS-producing cells. Thus, matrix association and reinforcement must precede recruitment of new cells. Because larger biofilms are more susceptible to disruption by mechanical stress, proteolytic regulation of recruitment allows recent recruits to reinforce their association with the biofilm matrix before attachment of new cells. This developmental program may yield a biofilm that is better able to withstand the high-shear estuarine environments in which V. cholerae is found.

Materials and Methods

Bacterial Strains, Plasmids, and Media.

Details of the bacterial strains and plasmids used in this study are listed in Tables S2 and S3. Media and strain construction are described in SI Materials and Methods and Table S4.

Table S2.

Strains

Strains Genotype Source
Escherichia coli
 SM10λpir thi thr leu tonA lacY supE recA::RP4-2-Tc::Muλpir R6K; Kmr J. Mekalanos, Harvard Medical School, Boston
V. cholerae
 PW357 O139 MO10 lacZ::vpsLp→lacZ; Smr (14)
 PW397 PW357 ΔvpsIΔvpsIl (3)
 PW707 PW357 Δbap1ΔrbmC (16)
 PW1397 C6706 lacZ J. Mekalanos
 PW1616 PW357 rbmA-FLAG This study
 PW1617 PW357 rbmA-FLAG ΔhapA This study
 PW1618 PW357 rbmA-FLAG ΔhapΔprtVΔVC0157 This study
 PW1704 PW357 rbmA-FLAG ΔVC0157 This study
 PW1705 PW357 rbmA-FLAG ΔprtV This study
 PW1706 PW357 rbmA-FLAG ΔhapΔprtV This study
 PW1707 PW357 rbmA-FLAG ΔhapΔVC0157 This study
 PW1708 C6706 lacZ rbmA-FLAG This study
 PW1709 C6706 lacZ rbmA-FLAG ΔhapA This study
 PW1710 C6706 lacZ rbmA-FLAG ΔVC0157 This study
 PW1711 C6706 lacZ rbmA-FLAG ΔhapΔprtV This study
 PW1712 C6706 lacZ rbmA-FLAG ΔhapΔVC0157 This study
 PW1713 C6706 lacZ rbmA-FLAG ΔhapΔprtVΔVC0157 This study
 PW1714 C6706 lacZ ΔrbmA This study
 PW1715 O139 MO10 ΔvpsL-QΔrbmA This study
 PW1716 O139 MO10 ΔvpsL-QΔrbmAwbfR This study
 PW856 O139 MO10 with GFP in lacZ site (3)
 PW1701 O139 MO10 with tomato in lacZ site This study

Kmr, kanamycin resistance; Smr, streptomycin resistance.

Table S3.

Plasmids

Plasmids Description Source
pRbmA FLAG-tagged full-length RbmA in pFLAG-CTC (16)
pRbmA* FLAG-tagged RbmA* in pFLAG-CTC This study
p[Sec]RbmA FLAG-tagged RbmA without the Sec signal in pFLAG-CTC This study
p[Sec+]RbmA* FLAG-tagged RbmA* with the Sec signal in pFLAG-CTC This study
pRbmA*-RTX RbmA fused to RtxA T1SS in pFLAG-CTC This study
pRbmA-RTX RbmA* fused to RtxA T1SS in pFLAG-CTC This study
pFLAG-CTC Control vector Sigma
pBADLacZ Control vector Invitrogen
pTagA VC0820 in pBAD-TOPO This study
pVCA0148 VCA0148 in pBAD-TOPO This study
pHAP VCA0865 in pBAD-TOPO This study
pPrtV VCA0223 in pBAD-TOPO This study
pVC1650 VC1650 in pBAD-TOPO This study
pVC0157 VC0157 in pBAD-TOPO This study
pVesA VCA0803 in pBAD-TOPO This study
pVesB VCA1200 in pBAD-TOPO This study
pVesC VC1649 in pBAD-TOPO This study
pWM91 oriR6KmobRP4 lacI pTac tnp miniTn10Km B. Wanner, Purdue University,  West Lafayette, IN
pWM91::ΔrbmA pWM91 carrying a fragment of rbmA harboring an unmarked internal deletion (16)
pWM91::rbmA-FLAG pWM91 encoding the C terminus of RbmA fused to a FLAG-tag with flanking DNA for recombination onto the chromosome This study
pWM91::ΔhapA pWM91 carrying a fragment of hapA harboring an unmarked internal deletion This study
pWM91::ΔrbmA pWM91 carrying a fragment of rbmA harboring an unmarked internal deletion This study
pWM91::ΔprtV pWM91 carrying a fragment of prtV harboring an unmarked internal deletion This study
pWM91::ΔVC0157 pWM91 carrying a fragment of VC0157 harboring an unmarked internal deletion This study
pGP704::rbmA-FLAG pGP704 carrying the 3′ end of rbmA encoding a FLAG-tag; Apr (16)

Table S4.

Primers

Primers Description
Construction of V. cholerae hapA deletion
 VCA0865P1 GCAGGTGCAGATGCCAAATCC
 VCA0865P2 TAACGAGCGGCCGCACATTTCTCAATCCTAGAGATGTTG
 VCA0865P3 TGCGGCCGCTCGTTATAACTTCCTTGCCACCTACCTG
 VCA0865P4 GCAGAAAAAATGGTGGGCAATATCG
Construction of V. cholerae prtV deletion
 VCA0223P1 GTCATTTATTCGATTGATGATTTG
 VCA0223P2 TAACGAGCGGCCGCACATTTTATTTCCTTAATATTTC
 VCA0223P3 TGCGGCCGCTCGTTATAATTCTTCCTTCTCCTTCCATG
 VCA0223P4 GCGAATTGGCGATCGAAAAGC
Construction of V. cholerae VC0157 deletion
 VC0157P1 GATATAGTTTAATTGCGGCAAG
 VC0157P2 TAACGAGCGGCCGCACATGATAAGTTTCCTTAAAAAG
 VC0157P3 TGCGGCCGCTCGTTATAACATGACGCATTAAACAATAAAAGC
 VC0157P4 CCAAAACGTAATAGGTGAGAGC
Construction of V. cholerae rbmA chromosomal fusion to FLAG-tag
 RbmA-FlagInsP1 CTTACTGATGGTCGTATGTTG
 RbmA-FlagInsP2 CTTGTCGTCATCGTCCTTGTAGTCTTTTTTTACCACTGTCATTGACTG
 RbmA-FlagInsP3 GACTACAAGGACGATGACGACAAGTAAATTTACCTAGTCACTTAGTCG
 RbmA-FlagInsP4 GCATCAATGACCCAAACAACC
Construction of RbmA* protein expression plasmid
 Forward AGAGGT CCATGGGT AAG TAT TGG CTG AGC ATT AAA GGC
 Reverse GAGAGT CTCGAG CTT CTT CAC CAC GGT CAT TGA TTG TTC C

Mixing Experiments to Determine the Role of VPS in Proteolysis.

Suspensions of the indicated V. cholerae strains were added in equal amounts to LB to yield an OD655 of 0.1. After 24 h, EDTA was added to the indicated samples. At 48 h, 150 μL of Laemmli buffer was added to the entire culture, boiled for 10 min, and analyzed by Western blotting.

Biofilm Assays.

Biofilm formation was quantified as previously described (10).

Cell-Binding Assays.

The ΔrbmA or ΔrbmAΔvpsL mutants were incubated with shaking until an OD655 of 3.5–4 was reached. Cells were pelleted and resuspended in fresh LB broth. Purified RbmA or RbmA* was added to cell suspensions, and the mixture was incubated for 1 h. Cells were transferred to a new tube, washed three times with PBS, and collected by centrifugation. Cell-associated RbmA or RbmA* was assessed by Western blot analysis.

Biofilm Recruitment Assays.

The indicated strains were incubated statically in wells containing coverslips for 24 h. Coverslips were washed twice with PBS and then incubated for 1 h with a GFP-labeled ΔvpsL cell suspension, as well as purified RbmA* where indicated. Coverslips were washed six times, mounted, and viewed with a Zeiss LSM 700 microscope. For analysis of ΔrbmA biofilms, cells were stained with DAPI (0.5 μg/mL). Volocity software (PerkinElmer) was used to quantify biofilm-attached ΔvpsL cells per field. At least two random fields of view in two biofilms were evaluated for each condition. This experiment was repeated twice with similar results.

Coincubation Assays.

Tomato-labeled V. cholerae carrying either an empty vector or a plasmid encoding HAP was cocultured in wells with a GFP-labeled ΔvpsL mutant. Where indicated, RbmA* was also added to a final concentration of 25 μg/mL. After 24 h, a portion of the pellicle was gently transferred to a slide, covered with a coverslip, and imaged using an LSM 700 microscope. Volocity software was used to quantify the number of ΔvpsL mutant cells per volume of WT cells. The ΔvpsL mutant cells were identified using a minimum size of 1 μm3. Cell clusters were subsequently separated using an object size guide of 1 μm3. Two randomly selected fields of view were evaluated in each of three pellicles. This experiment was repeated twice with similar results.

SI Materials and Methods

Growth Media.

Bacteria were grown in LB broth. When required, streptomycin (Sm; 100 μg/mL) and ampicillin (50 or 100 μg/mL, as noted) were added to the growth medium. Protein expression was induced with isopropyl-d-1-thiogalactopyranoside or 0.02% or 0.05% l-arabinose as indicated. EGTA, EDTA, a protease inhibitor mix mixture (Sigma), 1 mM 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride, or 2 mM PMSF was added to biofilms for protease inhibition experiments.

Generation of Deletion Mutants and Chromosomal rbmA with a 3′ FLAG-Tag Sequence.

For protease surveys in the C6706 background, RbmA was tagged by insertion of a suicide plasmid (15). Gene deletions and unmarked chromosomal protein tags were engineered using the splice overlap extension (SOE) method and double homologous recombination (15). The primers used for mutant generation are listed in Table S4.

Construction of Expression Plasmids.

The protease expression plasmids were constructed by cloning genes from V. cholerae MO10 into the pBadTOPO vector using a 5′ primer containing a stop codon followed by a ribosome binding site and a 3′ primer with a STOP codon. SOE was used to construct the rbmA/rtxA fusions, which were then cloned into pFLAG-CTC expression vector (Sigma).

Biofilm Assays.

Three hundred microliters of a cell suspension diluted to an OD655 of 0.05 in LB broth was dispensed into three borosilicate tubes, and these tubes were incubated at 27 °C. At the indicated time, the density of planktonic cells was assessed by OD655. The remaining biofilm or pellicle was dispersed by vortexing for 1 min with 1-mm-diameter glass beads in PBS [30% (vol/vol); BioSpec Products, Inc.], and the OD655 of the resulting cell suspension was measured.

Western Blot Analysis.

For detection of RbmA-FLAG in biofilms, the planktonic cells were removed, 300 μL of Laemmli buffer was added, samples were boiled for 10 min, and 10 μL of this lysate was loaded onto a 4–20% acrylamide gel (Pierce). After separation, proteins were transferred to a PVDF membrane using a semidry transfer method and detected using an anti-FLAG antibody. The membrane was then incubated overnight at 4 °C in a blocking solution consisting of TBS with 0.1% Tween 20 (TBS-T) and 5% (wt/vol) skim milk. Blocking solution was removed and replaced with fresh blocking solution supplemented with an HRP-conjugated anti-FLAG–binding antibody (Sigma) at a dilution of 1:5,000 or 1:10,000. After incubation for 1 h, the membrane was washed three times with TBS-T and detected with ECL Plus Western blotting detection reagent (Pierce).

Purification of RbmA and RbmA*.

These proteins were purified as previously described (20).

Calculation of Surface Electrostatic Potentials and Preparation of Structures.

Structures were prepared using RbmA model 4BE6 in PyMOL (20). The RbmA* model was manually generated by editing the 4BE6 structure and removing all amino acids from the N terminus up to K75. Then, the Adaptive Poisson Boltzman Software (APBS) package was used as for the unedited RbmA structure, whereas surface electrostatic potentials were calculated via the APBS package and PDB2PQR conversion software. Using the PyMOL APBS tools plug-in with standard settings, solvent-accessible surface potentials were then displayed at ±2 kT/e, where k is the Boltzman constant, T is temperature, and e is the electron charge (red for negative, blue for positive).

Cell-Binding Assays.

The ΔrbmA or ΔrbmAΔvpsL mutants were diluted to an OD655 of 0.001 and incubated at 27 °C with shaking until an OD655 of 3.5–4 was reached (∼18 h). Cells were pelleted and resuspended in fresh LB broth. Purified RbmA or RbmA* was added to cell suspensions in a 10-μg/mL ratio, and the mixture was incubated for 1 h at room temperature. Cells were transferred to a new tube, washed three times with PBS, and collected by centrifugation. Cell-associated RbmA or RbmA* was assessed by Western blot analysis. A smaller band was consistently present after incubation of RbmA* with cells, which likely represents a degradation product.

Biofilm Recruitment Assays.

The indicated strains were incubated statically starting from an OD655 of 0.05 in wells containing 18 × 18-mm coverslips for 24 h at 27 °C. Coverslips were removed, washed twice with PBS, and then incubated for 1 h with a GFP-labeled ΔvpsL cell suspension adjusted to an OD655 of 0.5 and supplemented with purified RbmA* (40 μg/mL) where indicated. Following incubation, the coverslip was washed six times, mounted, and viewed with a Zeiss LSM 700 microscope. For analysis of ΔrbmA mutant biofilms, cells were stained with DAPI (0.5 μg/mL). Volocity software (PerkinElmer) was used to quantify biofilm-attached ΔvpsL cells in a z-axis projection. At least two random fields of view in two biofilms were evaluated for each condition. This experiment was repeated twice with similar results.

Coincubation Assays.

Tomato-labeled V. cholerae carrying either an empty vector or a plasmid encoding HAP was cocultured in wells with a GFP-labeled ΔvpsL mutant at a ratio of 100:1 in LB broth supplemented with Sm and arabinose. Where indicated, RbmA* was also added to a final concentration of 25 μg/mL. After 24 h, a portion of the pellicle was gently transferred to a slide, covered with a coverslip, and imaged using an LSM 700 microscope. Volocity software was used to quantify the number of ΔvpsL mutant cells per volume of WT cells. The ΔvpsL mutant cells were identified using a minimum size of 1 μm3. Cell clusters were subsequently separated using an object size guide of 1 μm3. Two randomly selected fields of view were evaluated in each of three pellicles. This experiment was repeated twice with similar results.

Statistical Methods.

At least three experimental replicates were performed for each quantitative analysis. Error bars represent the SD, and statistical significance (P < 0.05) was calculated using a Student’s t test.

Acknowledgments

We thank Dr. John Mekalanos for providing us with the C6706 transposon library. Microscopy was performed at the Intellectual and Developmental Disabilities Research Center Imaging Facility. This work was supported by NIH Grants AI097612 and AI115023 (to P.I.W.) and NIH Grant T32HD055148 (to D.R.S.).

Footnotes

The authors declare no conflict of interest.

This article is a PNAS Direct Submission.

This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1512424112/-/DCSupplemental.

References

  • 1.Sack RB, et al. A 4-year study of the epidemiology of Vibrio cholerae in four rural areas of Bangladesh. J Infect Dis. 2003;187(1):96–101. doi: 10.1086/345865. [DOI] [PubMed] [Google Scholar]
  • 2.Huq A, et al. A simple filtration method to remove plankton-associated Vibrio cholerae in raw water supplies in developing countries. Appl Environ Microbiol. 1996;62(7):2508–2512. doi: 10.1128/aem.62.7.2508-2512.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Purdy AE, Watnick PI. Spatially selective colonization of the arthropod intestine through activation of Vibrio cholerae biofilm formation. Proc Natl Acad Sci USA. 2011;108(49):19737–19742. doi: 10.1073/pnas.1111530108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Taylor RK, Miller VL, Furlong DB, Mekalanos JJ. Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin. Proc Natl Acad Sci USA. 1987;84(9):2833–2837. doi: 10.1073/pnas.84.9.2833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Kirn TJ, Jude BA, Taylor RK. A colonization factor links Vibrio cholerae environmental survival and human infection. Nature. 2005;438(7069):863–866. doi: 10.1038/nature04249. [DOI] [PubMed] [Google Scholar]
  • 6.Stauder M, Vezzulli L, Pezzati E, Repetto B, Pruzzo C. Temperature affects Vibrio cholerae O1 El Tor persistence in the aquatic environment via an enhanced expression of GbpA and MSHA adhesins. Environ Microbiol Rep. 2010;2(1):140–144. doi: 10.1111/j.1758-2229.2009.00121.x. [DOI] [PubMed] [Google Scholar]
  • 7.Meibom KL, et al. The Vibrio cholerae chitin utilization program. Proc Natl Acad Sci USA. 2004;101(8):2524–2529. doi: 10.1073/pnas.0308707101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Reguera G, Kolter R. Virulence and the environment: a novel role for Vibrio cholerae toxin-coregulated pili in biofilm formation on chitin. J Bacteriol. 2005;187(10):3551–3555. doi: 10.1128/JB.187.10.3551-3555.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Chiavelli DA, Marsh JW, Taylor RK. The mannose-sensitive hemagglutinin of Vibrio cholerae promotes adherence to zooplankton. Appl Environ Microbiol. 2001;67(7):3220–3225. doi: 10.1128/AEM.67.7.3220-3225.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Houot L, Chang S, Pickering BS, Absalon C, Watnick PI. The phosphoenolpyruvate phosphotransferase system regulates Vibrio cholerae biofilm formation through multiple independent pathways. J Bacteriol. 2010;192(12):3055–3067. doi: 10.1128/JB.00213-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Mueller RS, Beyhan S, Saini SG, Yildiz FH, Bartlett DH. Indole acts as an extracellular cue regulating gene expression in Vibrio cholerae. J Bacteriol. 2009;191(11):3504–3516. doi: 10.1128/JB.01240-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Karatan E, Duncan TR, Watnick PI. NspS, a predicted polyamine sensor, mediates activation of Vibrio cholerae biofilm formation by norspermidine. J Bacteriol. 2005;187(21):7434–7443. doi: 10.1128/JB.187.21.7434-7443.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.McGinnis MW, et al. Spermidine regulates Vibrio cholerae biofilm formation via transport and signaling pathways. FEMS Microbiol Lett. 2009;299(2):166–174. doi: 10.1111/j.1574-6968.2009.01744.x. [DOI] [PubMed] [Google Scholar]
  • 14.Haugo AJ, Watnick PI. Vibrio cholerae CytR is a repressor of biofilm development. Mol Microbiol. 2002;45(2):471–483. doi: 10.1046/j.1365-2958.2002.03023.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Beyhan S, Odell LS, Yildiz FH. Identification and characterization of cyclic diguanylate signaling systems controlling rugosity in Vibrio cholerae. J Bacteriol. 2008;190(22):7392–7405. doi: 10.1128/JB.00564-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Absalon C, Van Dellen K, Watnick PI. A communal bacterial adhesin anchors biofilm and bystander cells to surfaces. PLoS Pathog. 2011;7(8):e1002210. doi: 10.1371/journal.ppat.1002210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Yildiz FH, Schoolnik GK. Vibrio cholerae O1 El Tor: Identification of a gene cluster required for the rugose colony type, exopolysaccharide production, chlorine resistance, and biofilm formation. Proc Natl Acad Sci USA. 1999;96(7):4028–4033. doi: 10.1073/pnas.96.7.4028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Moorthy S, Watnick PI. Identification of novel stage-specific genetic requirements through whole genome transcription profiling of Vibrio cholerae biofilm development. Mol Microbiol. 2005;57(6):1623–1635. doi: 10.1111/j.1365-2958.2005.04797.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Fong JC, Karplus K, Schoolnik GK, Yildiz FH. Identification and characterization of RbmA, a novel protein required for the development of rugose colony morphology and biofilm structure in Vibrio cholerae. J Bacteriol. 2006;188(3):1049–1059. doi: 10.1128/JB.188.3.1049-1059.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Giglio KM, Fong JC, Yildiz FH, Sondermann H. Structural basis for biofilm formation via the Vibrio cholerae matrix protein RbmA. J Bacteriol. 2013;195(14):3277–3286. doi: 10.1128/JB.00374-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Maestre-Reyna M, Wu WJ, Wang AH. Structural insights into RbmA, a biofilm scaffolding protein of V. cholerae. PLoS One. 2013;8(12):e82458. doi: 10.1371/journal.pone.0082458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Berk V, et al. Molecular architecture and assembly principles of Vibrio cholerae biofilms. Science. 2012;337(6091):236–239. doi: 10.1126/science.1222981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Boyd CD, Chatterjee D, Sondermann H, O’Toole GA. LapG, required for modulating biofilm formation by Pseudomonas fluorescens Pf0-1, is a calcium-dependent protease. J Bacteriol. 2012;194(16):4406–4414. doi: 10.1128/JB.00642-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Jude BA, Martinez RM, Skorupski K, Taylor RK. Levels of the secreted Vibrio cholerae attachment factor GbpA are modulated by quorum-sensing-induced proteolysis. J Bacteriol. 2009;191(22):6911–6917. doi: 10.1128/JB.00747-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Cameron DE, Urbach JM, Mekalanos JJ. A defined transposon mutant library and its use in identifying motility genes in Vibrio cholerae. Proc Natl Acad Sci USA. 2008;105(25):8736–8741. doi: 10.1073/pnas.0803281105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Booth BA, Boesman-Finkelstein M, Finkelstein RA. Vibrio cholerae soluble hemagglutinin/protease is a metalloenzyme. Infect Immun. 1983;42(2):639–644. doi: 10.1128/iai.42.2.639-644.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Nadell CD, Drescher K, Wingreen NS, Bassler BL. Extracellular matrix structure governs invasion resistance in bacterial biofilms. ISME J. 2015;9(8):1700–1706. doi: 10.1038/ismej.2014.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Boardman BK, Satchell KJ. Vibrio cholerae strains with mutations in an atypical type I secretion system accumulate RTX toxin intracellularly. J Bacteriol. 2004;186(23):8137–8143. doi: 10.1128/JB.186.23.8137-8143.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Boyd CD, et al. Structural features of the Pseudomonas fluorescens biofilm adhesin LapA required for LapG-dependent cleavage, biofilm formation, and cell surface localization. J Bacteriol. 2014;196(15):2775–2788. doi: 10.1128/JB.01629-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Hinsa SM, Espinosa-Urgel M, Ramos JL, O’Toole GA. Transition from reversible to irreversible attachment during biofilm formation by Pseudomonas fluorescens WCS365 requires an ABC transporter and a large secreted protein. Mol Microbiol. 2003;49(4):905–918. doi: 10.1046/j.1365-2958.2003.03615.x. [DOI] [PubMed] [Google Scholar]
  • 31.Hinsa SM, O’Toole GA. Biofilm formation by Pseudomonas fluorescens WCS365: A role for LapD. Microbiology. 2006;152(Pt 5):1375–1383. doi: 10.1099/mic.0.28696-0. [DOI] [PubMed] [Google Scholar]
  • 32.Navarro MV, et al. Structural basis for c-di-GMP-mediated inside-out signaling controlling periplasmic proteolysis. PLoS Biol. 2011;9(2):e1000588. doi: 10.1371/journal.pbio.1000588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Newell PD, Monds RD, O’Toole GA. LapD is a bis-(3′,5′)-cyclic dimeric GMP-binding protein that regulates surface attachment by Pseudomonas fluorescens Pf0-1. Proc Natl Acad Sci USA. 2009;106(9):3461–3466. doi: 10.1073/pnas.0808933106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Roche FM, Meehan M, Foster TJ. The Staphylococcus aureus surface protein SasG and its homologues promote bacterial adherence to human desquamated nasal epithelial cells. Microbiology. 2003;149(Pt 10):2759–2767. doi: 10.1099/mic.0.26412-0. [DOI] [PubMed] [Google Scholar]
  • 35.Conlon BP, et al. Role for the A domain of unprocessed accumulation-associated protein (Aap) in the attachment phase of the Staphylococcus epidermidis biofilm phenotype. J Bacteriol. 2014;196(24):4268–4275. doi: 10.1128/JB.01946-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Geoghegan JA, et al. Role of surface protein SasG in biofilm formation by Staphylococcus aureus. J Bacteriol. 2010;192(21):5663–5673. doi: 10.1128/JB.00628-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Conrady DG, Wilson JJ, Herr AB. Structural basis for Zn2+-dependent intercellular adhesion in staphylococcal biofilms. Proc Natl Acad Sci USA. 2013;110(3):E202–E211. doi: 10.1073/pnas.1208134110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Rohde H, et al. Induction of Staphylococcus epidermidis biofilm formation via proteolytic processing of the accumulation-associated protein by staphylococcal and host proteases. Mol Microbiol. 2005;55(6):1883–1895. doi: 10.1111/j.1365-2958.2005.04515.x. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES